Status:
COMPLETED
Factors Affecting Androgen Deprivation Therapy Choice in Prostate Cancer Patients
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
The objective of this study is to investigate possible factors that will affect the choice of androgen deprivation therapy in prostate cancer patients. This is a cross-sectional study performed in Pri...
Detailed Description
The incidence of prostate cancer in Hong Kong almost tripled between 1996 and 2010, with the highest increased incidence rate in total forms of malignancy. The incidence of prostate cancer in Hong Kon...
Eligibility Criteria
Inclusion
- Prostate cancer only happens in male patients
- Patients who are currently receiving at least one dose of LHRH agonist or antagonist, as androgen deprivation therapy
- Patients who are willing to consent and participate in this study
Exclusion
- Patients who received bilateral orchidectomy as androgen deprivation therapy
- Patients who, in the opinion of investigators, are not able to comprehend about the study questions
Key Trial Info
Start Date :
January 7 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05202340
Start Date
January 7 2022
End Date
February 28 2023
Last Update
June 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Shatin, Hong Kong